Knowledge hub

Drug Discovery

News

Can AI Stop the Cost Spiral in Drug Discovery? Summary of Our Expert Talk at BioTech X 2025

Abstract visualization of AI-driven analysis of patient data, representing precision medicine and responder identification.
Precision Trials: Using AI to Identify Responders
Portrait of Livia Legg, Chief Commercial Officer at Ardigen, featured in the 10 Years of Ardigen: Voices of Leadership interview series.
Built on Trust, Driven by Impact: How Ardigen’s CCO – Livia Legg Sees the Future of Partnerships in AI & Biotech
Illustration of Explainable AI in drug discovery, showing model interpretability and data transparency
Can You Trust Your Model? Why Explainability Matters in AI-Driven Drug Discovery
Learn how biotech can innovate faster and smarter. Discover how AI can benefit biologics’ discovery from protein design to in silico testing.
The AI-Biology Convergence: Designing the Next Generation of Biologics
Nature Methods cover image and cell morphology visualization from JUMP Cell Painting study
New publication in Nature Methods: How gene activity shapes cell structure
Scientist working in a laboratory environment, symbolizing biotech innovation and AI-driven drug discovery.
New publication: Biologically relevant models and AI increase scalability in CRC drug screening
Scientist analyzing high-content cell images on a computer screen – visualizing AI-driven phenotypic profiling in drug discovery.
The Future of Drug Discovery: Integrating Phenotypic Data with Omics and AI
a biopharma lab
Blog

What’s trending in European Biopharma? A look ahead

banner that introduces blog post a key take aways from the Drug Discovery Conference
Data dreams and drug design: What we learned at Discovery and Development Europe 2025
BIO Convention 2025
BIO International Convention 2025 – New Standards in Collaboration, Innovation, and the Integration of AI in Biotechnology
Biologics 2.0 – From monoclonal antibodies to multispecific therapeutics
High-performance computing servers powering biomedical data pipelines and drug discovery.
Beyond the Petabytes: What It Really Takes to Power the Next Leap in Drug Discovery
Ardigen co-organizes CVPR 2025 workshop on Computer Vision for Drug Discovery
Two scientists observing AI-driven cell analysis on a digital screen, representing decision-making in biotech innovation.
Build or Buy? Strategic Considerations for Biotech Companies Implementing AI Solutions
biotech US market
AI in biotech: What the US market got right (and what it’s still learning)
an Majta presenting on AI and omics data in drug discovery at NextGen Omics Conference 2025.
From Data Chaos to Drug Discovery – Ardigen Talk at NextGen Omics Conference